Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance
Antibiotics · 11.09.2025 · 14 (9) · 918
DOI: 10.3390/antibiotics14090918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 11.09.2025. Verfasst von Carina Alexandra Bandac und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Renal Transplantation, "C.I. Parhon" University Hospital, 700115 Iasi, Romania. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Urinary tract infections (UTIs) caused by carbapenem-resistant pathogens are increasingly common and pose serious treatment challenges due to limited antibiotic options and high complication rates. Identifying patients at risk is essential for guiding empirical therapy and improving outcomes. The primary objective of this study was to identify risk factors associated with carbapenem-resistant (CR) UTIs by comparing them with carbapenem-susceptible (CS) UTIs. Secondary objectives included analyzing the types of microorganisms involved in both groups, their antibiotic susceptibility profiles, and the presence of carbapenemase enzymes among CR UTI cases.
Method
We conducted a retrospective case-control study involving 127 hospitalized patients with UTIs caused by CR microorganisms and 91 patients with UTIs caused by multidrug-resistant (MDR) strains that retain susceptibility to carbapenems, admitted between 1 October 2023, and 31 March 2025.
Results
In univariate analysis, CR UTI patients had significantly higher rates of neoplasia, neurological disorders, urosepsis at admission, septic shock, the presence of urinary catheters at diagnosis, permanent nephrostomy catheters, hospitalizations within the past 180 days, previous antibiotic exposure including carbapenems, and recent urological procedures. Multivariate analysis revealed four independent risk factors for CR UTIs: neoplasia (OR = 2.152; 95% CI: 1.044–4.436; p = 0.038), neurological disorders (OR = 7.427; 95% CI: 2.804–19.674; p < 0.0001), antibiotic use in the previous 180 days (OR = 2.792; 95% CI: 1.487–5.396; p = 0.001), and prior carbapenem treatment OR = 10.313; 95% CI: 1.277–83.248; p = 0.029). Most of the isolated organisms belonged to the Enterobacterales genus, with Klebsiella spp. and Pseudomonas aeruginosa being the most common pathogens in CR UTIs, accounting for over 90% of cases. Among patients tested for carbapenemase production, all but one tested positive for at least one carbapenemase.
Conclusions
Neoplasia, neurological disorders, recent antibiotic therapy, and prior carbapenem use were significantly associated with increased risk of developing CR UTIs. Klebsiella spp. and Pseudomonas aeruginosa were the predominant causative organisms, with New Delhi metallo-β-lactamase (NDM) and Klebsiella pneumoniae carbapenemase (KPC) being the most frequently identified resistance mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology and Renal Transplantation, "C.I. Parhon" University Hospital, 700115 Iasi, Romania.
- Department of Urology, Elytis Hospital, 700010 Iasi, Romania.
- Department of Morpho-Functional Sciences II, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania.
- Department of Infectious Diseases, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
- "St Parascheva" Clinical Hospital of Infectious Diseases, 700116 Iași, Romania.
- Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
ORCID-Profile: Pavel Onofrei, Ionela-Larisa Miftode, Vasile Lucian Boiculese, Theodor Florin Pantilimonescu, Viorel Dragoș Radu
Zitieren
APA
Bandac, C. A., Ristescu, C., Onofrei, P., Miftode, I. L., Radu, R., Boiculese, V. L., Pauna, A. R., Pantilimonescu, T. F., Luduşanu, A., & Radu, V. D. (2025). Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance. Antibiotics, 14(9), 918. https://doi.org/10.3390/antibiotics14090918
Vancouver
Bandac CA, Ristescu C, Onofrei P, Miftode IL, Radu R, Boiculese VL, et al. Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance. Antibiotics. 2025;14(9):918. doi:10.3390/antibiotics14090918
BibTeX
@article{Bandac2025,
author = {Bandac, Carina Alexandra and Ristescu, Constantin and Onofrei, Pavel and Miftode, Ionela-Larisa and Radu, Rodica and Boiculese, Vasile Lucian and Pauna, Ana-Maria Raluca and Pantilimonescu, Theodor Florin and Luduşanu, Andreea and Radu, Viorel Dragoș},
title = {Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {9},
pages = {918},
doi = {10.3390/antibiotics14090918}
}
EUVIMED